We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PMVP market cap is 64.68M. The company's latest EPS is USD -1.3326 and P/E is -0.93.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.63M | -18.9M | -18.22M | -20.17M | -21.89M |
| Net Income | -16.64M | -15.76M | -15.27M | -1.21M | -19.23M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -26.64M | -34.94M | -58.29M | -77.04M | -80.13M |
| Net Income | -25.35M | -34.44M | -57.85M | -73.32M | -68.96M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 261.03M | 252.15M | 236.88M | 237.54M | 223.5M |
| Total Liabilities | 23.42M | 26.46M | 24.2M | 23.22M | 25.59M |
| Total Equity | 237.61M | 225.69M | 212.68M | 214.32M | 197.91M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 103.03M | 365.53M | 331.57M | 270.31M | 252.15M |
| Total Liabilities | 4.57M | 6.41M | 23.01M | 24.28M | 26.46M |
| Total Equity | -70.47M | 359.12M | 308.56M | 246.03M | 225.69M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -43.57M | -55.66M | -16.18M | -17.78M | -34.62M |
| Investing | -47.96M | -50.55M | 26.17M | 28.49M | 45.61M |
| Financing | 35.29M | 35.58M | N/A | 141k | 141k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -22.07M | -32.74M | -46.57M | -63.76M | -55.66M |
| Investing | 3.23M | 27.91M | -143.58M | -1.37M | -50.55M |
| Financing | 61.81M | 292.97M | 2.02M | 958k | 35.58M |
| Market Cap | 64.68M |
| Price to Earnings Ratio | -0.93 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.7 |
| Price to Book Ratio | 0.28 |
| Dividend Yield | - |
| Shares Outstanding | 51.75M |
| Average Volume (1 week) | 179.51k |
| Average Volume (1 Month) | 140.11k |
| 52 Week Change | -26.47% |
| 52 Week High | 2.26 |
| 52 Week Low | 1.20 |
| Spread (Intraday) | 0.11 (8.53%) |
| Company Name | PMV Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.pmvpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
